This post was sponsored by Amgen.

I am excited to share with you some extremely cool and worthwhile art installations popping up over the weekend!  

During this year’s ASCO Annual Meeting (McCormick Place, May 31 – June 4, 2019), Amgen Oncology will be highlighting how unique science can make a difference in cancer research through a collaboration with two Chicago artists, Nate Baranowski and Shaun Hays.

Amazing artwork pictured is by Nate Baranowski.  Nate is a street painter, muralist, and fine artist previously based in Tampa, FL and recently relocated to Chicago, IL.

Amgen Oncology has teamed up with local Chicago artists to bring science to life through hand-drawn, 3D chalk art installations throughout the city, timed to the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting this week. The chalk art installations will be unveiled June 1-2, and will showcase Amgen Oncology’s BiTE® (bispecific T-cell engager) technology– which is designed to harness the immune system to fight cancer. 

For every photo or social media post shared of the artwork using #BiTEtheEngager, Amgen Oncology will contribute to a science-based classroom campaign on DonorsChoose.org, to benefit Chicago Public Schools.  So please go to my Facebook and IG pages, then copy and/or screen shot and reshare these images with the hashtag #BiTEtheEngager

More about the technology…

BiTE® technology is a proprietary platform to Amgen, and important to the Company’s early oncology pipeline. 

This type of technology also has the potential to be engineered to target several different types of cancer.  The BiTE® campaign was created to raise awareness around the technology.  

Mechanism of Action:  BiTE® technology is a targeted immuno-oncology platform, meaning it is engineered to use the immune system to fight cancer. BiTE® molecules are designed to engage (or “bridge”) patients’ own immune system cells to a specific protein that appears on the surface of cancer cells. By creating this bridge, the immune system cells are potentially able to more clearly detect and fight cancer cells.